---
title: "Hemophagocytic lymphohistiocytosis"
alias: HLH
slug: "hemophagocytic-lymphohistiocytosis"
date: "2023-08-05"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[autoinflammatory syndromes]]

# Hemophagocytic lymphohistiocytosis

- â†‘â†‘ immune activity;
- failure to â†“ activated macrophages by NK cells/CTLs â†’ â†‘ cytokines (IFNÎ», IL18) â†’ macrophages phagocytize other blood cells, cytokine storm, organ failure
- Triggered by disruption of immune homeostasis:
  - immune activation (infxn, autoimmune flare) or immunodeficiency;
  - ~25% familial (mutations in perforin-mediated cytotoxicity)
- HLH 2/2 rheumatologic disease termed [[macrophage activation syndrome]] (MAS)
- Fever, â†‘ spleen, cytopenias, â†‘ TG, â†“ fibrinogen, â†‘ LFTs, hemophagocytosis, â†“ NK cell activity, â†‘ ferritin, â†‘ soluble IL2R;
- [[H-score]] for HLH likelihood (Arthritis Rheum 2014;66:2613)
- Rx trigger (eg, rheum flare w steroids/biologics);
  - if insufficient, [[HLH-04 protocol]]
    - etoposide + steroids Â± CsA Â± intrathecal MTX;
    - BMT if genetic or relapsed/refractory; Blood 2017;130:2728
  - anti-IL1/IVIg/steroids (Lancet Rheumatol 2020:2:e358),
  - emapalumab (anti-IFNÎ³) (NEJM 2020;382:1811);
- high mortality if no Rx (Blood 2019;133:2465)
